Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hirn

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
The EMBO Journal|March 1, 1985
Isolation of mouse N-CAM-related cDNA: detection and cloning using monoclonal antibodiesC Goridis, M Hirn, M J Santoni, et al.
Journal De Physiologie|January 1, 1985
Structural and functional studies on N-CAM neural cell adhesion moleculesM Hirn, H Deagostini-Bazin, G Gennarini, et al.
Lancet (London, England)|September 3, 1988
Anti-LEA1 monoclonal antibody and bone marrow graft rejection in adultsD Maraninchi, C Mawas, J Reiffers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Neuroscience|January 1, 1982
A new brain cell surface glycoprotein identified by monoclonal antibodyM Hirn, M Pierres, H Deagostini-Bazin, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
Leukemia & Lymphoma|August 26, 1998
Anti-GM-CSF monoclonal antibody therapy for refractory acute leukemiaR Bouabdallah, D Olive, P Meyer, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
The EMBO Journal|March 1, 1985
Isolation of mouse N-CAM-related cDNA: detection and cloning using monoclonal antibodiesC Goridis, M Hirn, M J Santoni, et al.
Journal De Physiologie|January 1, 1985
Structural and functional studies on N-CAM neural cell adhesion moleculesM Hirn, H Deagostini-Bazin, G Gennarini, et al.
Lancet (London, England)|September 3, 1988
Anti-LEA1 monoclonal antibody and bone marrow graft rejection in adultsD Maraninchi, C Mawas, J Reiffers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Neuroscience|January 1, 1982
A new brain cell surface glycoprotein identified by monoclonal antibodyM Hirn, M Pierres, H Deagostini-Bazin, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
Leukemia & Lymphoma|August 26, 1998
Anti-GM-CSF monoclonal antibody therapy for refractory acute leukemiaR Bouabdallah, D Olive, P Meyer, et al.
Pageof 9